Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 11 patents granted in the last 365 days
Hm Clause Inc. currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This single active matter is assigned to 1 distinct examiner and is being processed within 1 distinct art unit. The portfolio's current activity is highly focused, with no other pending actions or examiners currently involved in the patent prosecution process for this company.
The busiest examiner for the portfolio is MEADOWS, CHRISTINA L, who is responsible for 1 pending office action. As the sole examiner for the portfolio, MEADOWS, CHRISTINA L holds all of the current pending work. For a practitioner, this means that the immediate success of the patent strategy depends on the specific interactions with this one individual. With only 1 distinct examiner and 1 distinct art unit, there is no opportunity to compare different examination approaches or administrative standards. The prosecution is entirely centralized within this single technical and personnel channel. This 1 pending office action represents the total volume of current interactions with the patent office.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MEADOWS, CHRISTINA L | 1 | 74.3% | +25.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18799465 | HYBRID TOMATILLO PLANT NAMED BOTERO | MEADOWS, CHRISTINA L | 2d overdue |
| Art Unit | Apps |
|---|---|
| 1663 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18799465 | HYBRID TOMATILLO PLANT NAMED BOTERO | MEADOWS, CHRISTINA L | 1663 | §112 | Final Rejection | 2d overdue | Pending | Aug 09, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialHm Clause Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Christina L Meadows has the most, with 1 of Hm Clause Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
